Advanced search
Publication Cover
Substance Abuse Volume 41, 2020 - Issue 2
Journal homepage
10,592
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment

Traci C. GreenOpioid Policy Research Collaborative, Institute for Behavioral Health at The Heller School for Social Policy and Management, Brandeis University, Waltham, Massachussetts, USA; ;Department of Emergency Medicine and Epidemiology, The Warren Alpert School of Medicine of Brown University, Rhode Island Hospital, Providence, Rhode Island, USA;
, PhD, MSc,
Jeffrey BratbergUniversity of Rhode Island College of Pharmacy, Kingston, Rhode Island, USA; ORCID Iconhttps://orcid.org/0000-0002-2240-5768
, PharmD, FAPhAORCID Icon &
Deborah S. FinnellJohns Hopkins School of Nursing, Baltimore, Maryland, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7678-9640
, DNS, RN, CARN-AP, FAANORCID Icon
Pages 147-149 | Published online: 21 Apr 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Barak Shapira & Paola Rosca. (2023) Transformation of substance use disorder treatment services during COVID-19 - A lasting change?. Journal of Substance Use 28:4, pages 552-559.
Read now
Diana Sun, Amanda Graham, Ben Feldmeyer, Francis T. Cullen & Teresa C. Kulig. (2023) Public Opinion about America’s Opioid Crisis: Severity, Sources, and Solutions in Context. Deviant Behavior 44:4, pages 567-590.
Read now
Leslie W. Suen, Stacy Castellanos, Neena Joshi, Shannon Satterwhite & Kelly R. Knight. (2022) “The idea is to help people achieve greater success and liberty”: A qualitative study of expanded methadone take-home access in opioid use disorder treatment. Substance Abuse 43:1, pages 1147-1154.
Read now
Jared Wildberger, Kevin Wenzel & Marc Fishman. (2022) Assessing clinical impacts and attitudes related to COVID-19 among residential substance use disorder patients. Substance Abuse 43:1, pages 756-762.
Read now
Nicole Paul, Amy J. Kennedy, Simone Taubenberger, Judy C. Chang & Karen Hacker. (2022) Provider perceptions of medication for opioid used disorder (MOUD): A qualitative study in communities with high opioid overdose death rates. Substance Abuse 43:1, pages 742-748.
Read now
David Eapen-John, Ayeshah G. Mohiuddin & James L. Kennedy. (2022) A potential paradigm shift in opioid crisis management: The role of pharmacogenomics. The World Journal of Biological Psychiatry 23:6, pages 411-423.
Read now
Alicia L. Nobles, Derek C. Johnson, Eric C. Leas, David Goodman-Meza, María Luisa Zúñiga, Douglas Ziedonis, Steffanie A. Strathdee & John W. Ayers. (2021) Characterizing Self-Reports of Self-Identified Patient Experiences with Methadone Maintenance Treatment on an Online Community during COVID-19. Substance Use & Misuse 56:14, pages 2134-2140.
Read now
Nicky J. Mehtani, Jessica T. Ristau, Hannah Snyder, Colleen Surlyn, Joanna Eveland, Shannon Smith-Bernardin & Kelly R. Knight. (2021) COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management. Substance Abuse 42:2, pages 205-212.
Read now
Hamed Al Sinawi, Naser Al Balushi, Tamadhir Al-Mahrouqi, Abdullah Al Ghailani, Roopa K. McCall, Alya Sultan, Hilal Al Sabti, Abdullah Al Maniri, Sathiya Murthi Panchatcharam & Mohammed Al-Alawi. (2021) Predictors of psychological distress among the public in Oman amid coronavirus disease 2019 pandemic: a cross-sectional analytical study. Psychology, Health & Medicine 26:1, pages 131-144.
Read now
Shannon Mountain-Ray, Deborah Finnell, Payel Roy, Rebecca Northup & Doreen MacLane-Baeder. (2021) Confronting COVID, racism, and addiction: The association of multidisciplinary education and research in substance use and addiction (AMERSA). Substance Abuse 42:1, pages 1-4.
Read now
Allison M. Gustavson, Adam J. Gordon, Marie E. Kenny, Haley McHenry, Julie Gronek, Princess E. Ackland & Hildi J. Hagedorn. (2020) Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder. Substance Abuse 41:4, pages 413-418.
Read now
Gerald Cochran, Julie Bruneau, Nicholas Cox & Adam J. Gordon. (2020) Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Substance Abuse 41:3, pages 269-274.
Read now
Osnat C. Melamed, Tanya S. Hauck, Leslie Buckley, Peter Selby & Benoit H. Mulsant. (2020) COVID-19 and persons with substance use disorders: Inequities and mitigation strategies. Substance Abuse 41:3, pages 286-291.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.